Treatment of arterial hypertension in prognosis of acute myocardial ishemia. Clinical and genetic analysis
https://doi.org/10.18705/1607-419X-2006-12-3-222-226
Abstract
The aim of the study was to evaluated the role of ID ACE gene polymorphism in the development of acute myocardial ishemia in patients with arterial hypertension (HT). Patients with DD genotype were demonstrated a higher risk of myocardial infarction then patients with ID and II genotype. Conversely, the course of HT in II genotypic group is more favorable, but the efficacy of their treatment by traditional agents is minimal.
About the Authors
R. T. Saygitov
Russian Reseach Institute of Gerontology
Russian Federation
Russian Federation
M. G. Glezer
I.M. Sechenov Moscow Medical Academy
Russian Federation
Russian Federation
D. P. Sementsov
I.M. Sechenov Moscow Medical Academy
Russian Federation
Russian Federation
I. V. Kostomarova
Russian Reseach Institute of Gerontology
Russian Federation
Russian Federation
IN. A. Malygina
Russian Reseach Institute of Gerontology
Russian Federation
Russian Federation
References
1. Lenfant С. Гипертензия и ее последствия: состояние проблемы в мире. Артериальная гипертензия. 2005;. 11(2): 21-27.
2. Kearney P.M., Whelton М., Reynolds K., Whelton Ρ.Κ., He J. Worldwide prevalence of hypertension: a systematic review. J. Hypertens. 2004; 22(1):11-19.
3. Kearney P.M., Whelton М., Reynolds Κ., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455): 217-223.
4. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
5. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance ofusual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360(9349): 1903-1913.
6. Шальнова C.A., Деев А.Д., Оганов Р.Г., Шестов Д.Б. Роль систолического и диастолического артериального давления для прогноза смертности от сердечно-сосудистых заболеваний. Кардиоваскулярная терапия и профилактика. 2001; 2: 3-7.
7. Agerholm-Larsen В., Nordestgaard В.G., Tybjaerg-Hansen А. АСЕ gene polymorphism in cardiovascular disease: metaanalyses of small and large studies in whites. Arterioscler. Thromb. Vase. Biol. 2000: 20(2): 484-492.
8. Scharplatz M., Puhan M.A., Steurer J., Bachmann L.M. What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors? B.M.C. Med. Genet. 2004; 5: 23-28.
9. McNamara D.M., Holubkov R., Postava L., Janosko K., MacGowan G.A., Mathier M., Murali S., Feldman A.M., London B. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. J. Am. Coll. Cardiol. 2004; 44(10): 2019-2026.
10. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic. Acids. Res. 1988; 16(3): 1215.
11. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992; 20: 1433.
12. Steg Ph.G., Goldberg R.J., Gore J.M., Fox K.A.A., Eagle K.A., Flather M.D., Sadiq I., Kasper R., Rushton-Mellor S.Κ., Anderson F.A. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am. J. Cardiol. 2002; 90(4): 358-363.
13. Hasdai D., Behar S., Wallentin L., Danchin N., Gitt A.K., Boersma E., Fioretti P.M., Simoons M.L., Battler A. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur. Heart J. 2002; 23(15): 1190-1201.
14. Niu T., Chen X., Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs. 2002; 62(7): 977-993.
15. Сайгитов P.T., Малыгина H.A., Бойко Н.В., Глезер М.Г. Полиморфизм ангиотензинпревращающего фермента (АПФ) и эффективность монотерапии ингибиторами АПФ гипертрофии миокарда левого желудочка, развившейся на фоне гипертонической болезни. Геронтология и гериатрия. 2003; 2:263-267.
Review
For citations:
Saygitov R.T., Glezer M.G., Sementsov D.P., Kostomarova I.V., Malygina I.A. Treatment of arterial hypertension in prognosis of acute myocardial ishemia. Clinical and genetic analysis. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2006;12(3):222-226. (In Russ.) https://doi.org/10.18705/1607-419X-2006-12-3-222-226
Views:
921
Email this article 